In silico prediction, engineering and design are changing the way drugs will be discovered, designed and optimized in the future. These tools are still in their early development and much needs to be learned on how to adapt them for use in antibody and vaccine discovery, training, prediction, developability, simulation and optimization.
Scientific Advisory Board:
M. Frank Erasmus, PhD, Head, Bioinformatics, Specifica, Inc.
Victor Greiff, PhD, Associate Professor, Oslo University Hospital
Maria Wendt, PhD, Global Head and Vice President, Digital and Biologics Strategy and Innovation, Sanofi